HOME >> MEDICINE >> NEWS
NIAID Ebola vaccine enters human trial

searchers will also examine the volunteers' blood to look for signs of immune system reaction to the vaccine. Ultimately, the scientists envision this vaccine as the first in a two-stage vaccination strategy called prime-boost: after "priming" with the DNA vaccine, the immune system response is "boosted," or augmented, by a second inoculation with modified, non-disease-causing cold viruses that make selected Ebola proteins. The booster essentially sets the immune system on alert against future infection by Ebola virus.

In August, Dr. Nabel and his colleagues reported using the booster shot to quickly and completely protect monkeys against Ebola. A fast-acting vaccine would be of great use during an outbreak of Ebola. The full prime-boost strategy, which uses the DNA vaccine being tested in this study, elicits a stronger immune response and is important to pursue for individuals at high risk, such as health care workers. Dr. Nabel says that expanded human trials of Ebola vaccines using the prime-boost strategy could begin by 2005.


'"/>

Contact: Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
18-Nov-2003


Page: 1 2 3

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIAID Ebola vaccine enters human trial

(Date:2/28/2015)... February 28, 2015 Kaylie Corrigan, Outdoor ... treatment center , and current student obtaining her Masters ... implemented a weekly forum in psychoeducation on substance use ... Flagstaff, AZ as part of her studies. , “Even ... for support and counseling at the high school and ...
(Date:2/28/2015)... Viejo, California (PRWEB) February 28, 2015 Developers ... the release of a new overlay plugin for Final Cut ... Film Studios. , “FCPX Overlay Chromatic gives users total control ... said Christina Austin, CEO of Pixel Film Studios. “FCPX Overlay ... maintaining an easy to use interface.” , FCPX Overlay Chromatic ...
(Date:2/28/2015)... 28, 2015 The World Scout League ... materials to potential EMTs and firefighters, recently announced its ... a way to raise charitable donations for age-related research. ... Columbia, will be held on March 29, 2015; registration ... begin at 3:30 p.m. , To participate in ...
(Date:2/27/2015)... OnChip Devices , a world ... wire bondable, silicon ESD (Electrostatic Discharge) protection diodes targeted ... ESD88NP and ESD88PN are designed ... and IC products. These Zeners exhibit no device ... devices meet the requirements of IEC61000 and safely dissipate ...
(Date:2/27/2015)... February 27, 2015 On March ... and the National Cancer Institute (NCI) will co-host ... the National Institutes of Health (NIH), in Bethesda, ... is dedicated to medical professionals and scientists who ... to the general public, including patients, their families, ...
Breaking Medicine News(10 mins):Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3
(Date:2/26/2015)... , February 27, 2015 ... 2014 market research report to its store. This ... Ulcers, therapeutic pipeline. The report "Corneal ... the therapeutic development for Corneal Ulcers. Corneal Ulcers ... includes bacterial infections, viral infections & fungal infections. ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... its fourth quarter and full year 2014 financial results after ... In conjunction with the release, the Company will host a ... Eastern Time on Thursday, March 5, 2015 ... developments. Interested parties may access the live conference ...
(Date:2/26/2015)... 26, 2015 Every year many millions of ... heart disease.  Nevertheless, year after year doctors and the ... the first test to determine the status of heart ... or not, even though that technology is over 100 ... that doctors know, (while most patients do not know) ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2
Cached News: